MORELLI, Olivia
 Distribuzione geografica
Continente #
NA - Nord America 2.799
EU - Europa 1.877
AS - Asia 1.815
SA - Sud America 314
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 33
OC - Oceania 2
Totale 6.980
Nazione #
US - Stati Uniti d'America 2.677
SG - Singapore 812
IT - Italia 312
UA - Ucraina 293
VN - Vietnam 279
IE - Irlanda 274
SE - Svezia 253
BR - Brasile 252
RU - Federazione Russa 231
CN - Cina 224
HK - Hong Kong 211
DE - Germania 146
FR - Francia 112
FI - Finlandia 95
GB - Regno Unito 62
KR - Corea 54
BD - Bangladesh 44
CA - Canada 44
IN - India 42
TR - Turchia 25
AR - Argentina 23
IQ - Iraq 20
MX - Messico 19
AT - Austria 18
PL - Polonia 17
JP - Giappone 16
PK - Pakistan 15
UZ - Uzbekistan 15
BE - Belgio 14
VE - Venezuela 13
ZA - Sudafrica 13
CH - Svizzera 11
CR - Costa Rica 11
GT - Guatemala 10
ID - Indonesia 10
NL - Olanda 10
ES - Italia 9
JM - Giamaica 9
EC - Ecuador 8
SA - Arabia Saudita 8
PH - Filippine 7
CO - Colombia 6
PR - Porto Rico 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CZ - Repubblica Ceca 5
JO - Giordania 5
MA - Marocco 5
HN - Honduras 4
LB - Libano 4
LT - Lituania 4
PS - Palestinian Territory 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
EU - Europa 3
MY - Malesia 3
PY - Paraguay 3
SV - El Salvador 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
DM - Dominica 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
LY - Libia 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
SC - Seychelles 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GY - Guiana 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PW - Palau 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.847
Città #
Singapore 552
Chandler 292
Dublin 274
San Jose 257
Ashburn 231
Hong Kong 211
Dong Ket 177
San Mateo 141
Jacksonville 114
Santa Clara 111
Boardman 110
Council Bluffs 97
Moscow 88
Lauterbourg 70
Princeton 69
Medford 68
Ann Arbor 67
Beijing 66
Wilmington 57
Perugia 53
Altamura 50
Seoul 50
Andover 47
Los Angeles 41
Munich 38
New York 35
Ho Chi Minh City 31
Lawrence 31
Piscataway 27
São Paulo 25
The Dalles 24
Woodbridge 23
Des Moines 22
Dallas 21
Hanoi 20
Helsinki 20
Rome 20
Frankfurt am Main 17
Saint Petersburg 16
Tokyo 16
Norwalk 15
Brooklyn 14
Brussels 14
Orem 14
Falls Church 13
Chicago 11
Ottawa 11
Phoenix 11
Turku 11
Atlanta 10
Milan 10
Tashkent 10
Curitiba 9
Falkenstein 9
Guatemala City 9
Izmir 9
Nuremberg 9
Rio de Janeiro 9
Warsaw 9
Cattolica 8
Columbus 8
Da Nang 8
London 8
San José 8
Montreal 7
San Paolo di Civitate 7
Toronto 7
Baghdad 6
Brasília 6
Buffalo 6
Denver 6
Lahore 6
Mumbai 6
North Bergen 6
Salvador 6
Amman 5
Bari 5
Bologna 5
Boston 5
Charlotte 5
Foligno 5
Haiphong 5
Houston 5
Manchester 5
Mexico City 5
Palermo 5
Porto Alegre 5
Roubaix 5
San Francisco 5
Amsterdam 4
Ankara 4
Auburn Hills 4
Campinas 4
Cape Town 4
Caracas 4
Chengdu 4
Chennai 4
Fairfield 4
Goiânia 4
Johannesburg 4
Totale 4.109
Nome #
Acalasia esofagea: Caso clinico 162
Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. 157
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 153
A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon. 145
Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report 137
Administration of isoflavones enriched pasta reduces gastric emptying time in healthy volunteers 125
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 117
A simplified method for anal ultrasonography: preliminary report 116
Acalasia esofagea: Caso clinico 115
Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: comparison with endoscopic findings 114
Real-time gastric juice analysis with EndoFaster for H. pylori diagnosis: A large, multicentre study 112
NO-NSAIDs are ICE/caspase1 inhibitors and protect from citokine-mediated acute liver failure induced by Concanavalin A in mice. 111
Soy germ-enriched pasta containing isoflavones ameriorates gastric emptying time in diabetic patients. 109
Trattamento farmacologico della gastropatia da FANS. 106
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 106
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 106
A new aminoacid derivative of ursodeoxycholate, N-L-glutamyl-UDCA (UDCA-glu) to release selectively UDCA in the rat colon. 106
APPROCCIO AL PAZIENTE CON DIARREA 104
AN UNUSUALLY RAPID-ONSET PORTAL HYPERTENSION 100
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy 100
SINDROMI POST-GASTRECTOMIAE POST-VAGOTOMIA. 98
Indomethacin modulates Mac-1 expression on circulating neutrophils by inducing Ca2+ mobilization and tyrosine kinase activation. 98
Effect of NO donors and NO-aspirin on TNF release and gastric mucosal damage in rats and isolated macrophages 97
Nitric oxide-releasing NSAIDs inhibit interleukin 1beta converting enzyme-like cysteine proteases and protect endothelial cells from appopthosis induced by TNFx 97
Association between celiac disease and chronic hepatitis C 96
Approccio al paziente con gas e meteorismo 95
Nitric Oxide-derived NSAIDs inhibit ICE-like Cysteine Proteasis and protect from acute liver injury in a mice model of T-cell mediated hepatitis 95
LESIONI FOCALI EPATICHE MALIGNE 94
NCX 1000, an NO-derivative of ursodeoxycholic acid protects against Th1-mediated liver damage in mice. 93
NSAID-induced TNF alpha release from macrophages is the key mediator of gastric mucosal injury. 91
Amino acid derivatives of UDCA as novel prodrugs for colonic-specific drug delivery. 91
NO-NSAID gastrointestinal safety is related to inhibition of ICE-like Cysteine Proteases. New insights into the moleculare basis of NSAID gastropathy 89
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 88
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats. 88
NCX-1000, an NO derivative of UDCA, releases NO and protects against portal hypertension by inhibiting hepatic stellate cell contraction. 88
Nitric oxide-derived NSAIDs inhibit ICE-like Cysteine Proteases, IL-1β and IFNγ release and protect from Concanavallin A-induced acute liver injury 88
Real-time determination of gastric juice pH with EndoFaster® for atrophic gastritis assessment 87
Isoflavones in Soy-Germ Pasta Modulate the Expression of Human Gastric Genes Involved in Mucosal Defense 87
Gastroparesis: New insights into an old disease 87
Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder. 85
Fattori di rischio della gastropatia da FANS 84
Soy extract diet in rats to decrease liver steatosis induced by lieber-de carli modified diet 84
Advanced hepatocellular carcynoma: treatment with all-trans retinoic acid (ATRA) plus tomoxifen and vitamin E 84
An NO-derivative of ursodeoxycholic acid exerts Anti-apoptotic effects by inhibiting Fas-dependent activation of liver caspases 84
Malattie ereditarie del pancres 82
TNF alpha processing enzyme inhibitors prevent aspirin-induced TNF alpha release and protect against gastric mucosal injury in rats. 82
Acalasia esofagea: caso clinico 82
Upper Gastrointestinal Endoscopy Quality in Italy: A Nationwide Study 81
Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. 80
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats 79
Isoflavones in food with minimal soy protein reduce serum cholesterol and improve important markers of cardiovascular risk. 79
Acalasia Esofagea: caso clinico 78
Rectal bleeding due to ectopic variceal bleeding: the "emborrhoid'' technique as a bridge to TIPS placement 77
S.Fiorucci, E. Antonelli, O. Morelli, B.Federici, and A.Morelli. Prevention of gastric damage by NO-releasing aspirin (NCX-4016) is mediated by inhibition ICE-Like proteases in gastric mucosa and endothelial cells 74
A pilot study with all-trans retinoic acid plus tamoxifen and vitamin E in patients with hepatocellular carcinoma (HCC): a four years follow-up 74
Nitric oxide-releasing NSAIDs inhibit interleukin-1 beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNF alpha 74
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study 74
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 73
Macri’ G, Surrenti E, Ciancio G, Morelli O, Pignalosa P, Galli A, Salvadori G, Surrenti C. Amoxicillin, Clarithromycin, Azithromycin and Tinidazole for the eradication of Helicobacter pylori (Hp) infection in peptic ulcer patients: a random clinical trial 71
An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity 67
Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. 66
In vivo bombesin-stimulated pancreatic growth is mediated by direct angiogenetic effect on endothelial cells 66
Endoscopic ultrasonography-guided biliary drainage for malignant jaundice by using electrocautery-enhanced lumen-apposing metal stents (Hot-SPAXUS stent) 65
Lesioni epatiche benigne 65
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 64
PATOLOGIA MOTORIA E INFIAMMATORIA DELL’ESOFAGO: CASO CLINICO. 64
Oral anticoagulants and small intestinal bacterial overgrowth. 64
Upper endoscopy in elderly patients: a multicentre, cross-sectional study 59
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 59
Treatment strategy of hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation. A three-year follow-up study 58
Small intestinal bacterial overgrowth and warfarin dose requirement variability. 58
Inteleukin-10 reduces lethality and hepatic injury induced by lipopolysaccharide (LPS) in D-galactosamine (Galn) sensitized mice. 57
Lesioni focali epatiche benigne 56
The single photon emission tomography proves a reduction of cerebral blood flow in cirrhotic patients before the appearance of overt encephalopathy. 54
Expression of Platelet-Derived Growth Factor (PDGF) and Platelet Derived Growth Factor Receptor (PDGF-R) in a cholestatic model of rat liver fibrosis. 54
Treatment of All-Trans Retinoic Acid (ATRA) plus Tamoxifen and Vitamin E in patients with advanced hepatocellular carcynoma 51
Update on ozanimod for ulcerative colitis 49
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 48
Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) 48
EGF modulates Pepsinogen secretion in gastric isolated chief cells by activating multiple intracellular pathway. 47
The environmental impact of pediatric celiac disease diagnosis and follow‐up 32
Totale 6.980
Categoria #
all - tutte 31.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022417 0 0 0 41 20 10 10 185 10 4 57 80
2022/2023938 74 140 11 76 71 107 2 45 358 11 30 13
2023/2024333 20 45 22 9 4 3 60 7 39 18 54 52
2024/20251.061 5 105 48 33 179 55 82 88 149 53 183 81
2025/20262.041 157 194 119 228 247 168 323 97 226 165 87 30
2026/2027682 34 65 107 476 0 0 0 0 0 0 0 0
Totale 6.980